Lupin announces the launch of generic TriCor in the US
After securing the USFDA approval in December 2011, Lupin has launched the generic version of TriCor in the US market.
Mumbai, November 20, 2012: The Indian drug firm Lupin today announced the launch of the generic version of Abott Laboratories' cholesterol lowering drug TriCor in the US market.
It is worth noting here that Lupin received the US Food and Drug Administration approval for the generic fenofibrate drug last December.
The company said in a statement that TriCor tablets have annual sales worth US$ 1.26 billion in the US market.